Le Lézard
Classified in: Health, Business
Subjects: NPT, FNC, WOM

March of Dimes Awards Two Basil O'Connor Grants to Study Triggers of Labor Onset, Barriers to Postpartum Heart Health


ARLINGTON, Va., April 16, 2024 /PRNewswire/ -- March of Dimes, the leading organization fighting for the health of moms and babies, has awarded two doctors the Basil O'Connor Starter Scholar Research Awards, the organization's signature grants for up-and-coming scientists embarking on lifelong research paths.

Dr. Elizabeth Ann L. Enninga, PhD, an Assistant Professor of Obstetrics and Gynecology, and Immunology, at Minnesota's Mayo Clinic, and Dr. Mara Murray Horwitz, MD, MPH, an Assistant Professor of Medicine at Boston University and primary care clinician at Boston Medical Center, both received $150,000 grants.

Dr. Enninga's work will focus on the role of cell free (cf) fetal DNA on labor and preterm birth, which occurs before 37 weeks of pregnancy. The placenta releases cf fetal DNA into the maternal bloodstream during pregnancy. Dr. Enninga's previous work has shown that an increase in this DNA in the mom's body toward the end of pregnancy leads to an immune response which initiates already known features of labor.

Her Basil O'Connor work aims to further examine how this happens, setting the stage for the development of future tests that could identify women at risk of delivering early based on immune cell profiles and cf fetal DNA concentrations in their blood. Further, her research on these basic mechanisms may help identify new medicines that may delay preterm birth by blocking the maternal immune response.

With 1 in 10 babies born preterm in the US, the ultimate goal of her research is to define precisely how labor happens in the body to reduce preterm births and promote more successful inductions of labor, which could result in fewer Cesarean births and stillbirths. 

Dr. Murray Horwitz, for her part, will conduct research to understand health system barriers to achieving heart health and the overall health of women who have had a hypertensive disorder of pregnancy (HDP), such as preeclampsia, which affects 1 in 25 pregnancies in the US.  Her research will identify opportunities to improve outcomes for postpartum women, because HDPs signal that a person is at increased risk for future chronic hypertension and heart disease.

She'll focus on an intervention called patient navigation, where women with prior HDPs receive help from a support person who checks in on them frequently, assesses and provides counseling on their health history and social needs, and helps identify and connect them with primary care providers.

Her Basil O'Connor work will set the foundation for a planned randomized controlled trial (RCT) of postpartum patient navigation set to take place in 2027.

The Basil O'Connor awards, named for the first March of Dimes chairman and president, are part of March of Dimes' research strategy to address the multi-faceted nature of the maternal and infant health crisis with funding that supports discovery, translational and social science research, and data collection and analysis.

"Our Basil O'Connor awards support the next generation of consequential researchers in this field, and this year's winners exemplify that mission perfectly," said Dr. Emre Seli, Chief Scientific Advisor at March of Dimes. "While Dr. Enninga's research could one day lead to diagnostics and therapeutics that could delay and reduce preterm birth, Dr. Murray Horwitz's work could lead to enhanced access to healthcare for women with cardiovascular risks. Together, both are supporting our mission to reduce preventable maternal and infant mortality and morbidity."

Find more information about the Basil O'Connor Awards here.

About March of Dimes

March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs, and provide education and advocacy so that every family can have the best possible start. Since 1938, we've built a successful legacy to support every pregnant person and every family. Visit marchofdimes.org or nacersano.org for more information. Find us on Facebook and follow us with #marchofdimes and @marchofdimes.

SOURCE March of Dimes Inc.


These press releases may also interest you

at 09:07
Edible®, an innovative e-commerce hub uniquely supported by locally owned brick-and-mortar locations across the globe, today announced the appointment of Faraz Iqbal as Chief Technology Officer (CTO). With more than 25 years of experience and...

at 09:07
Often the first to feel the effects of inflation and economic volatility, small business owners are optimistic about their businesses, even as economic challenges remain. KeyBank's 2024 Small Business Survey found that 65% of small business owners...

at 09:05
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke, announced today that its first quarter 2024 financial results will be...

at 09:05
Schneider National, Inc. , a leading transportation and logistics services company, today announced results for the three months ended March 31, 2024. "The enterprise continued to feel the pressures of the ongoing freight recession in the first...

at 09:05
Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") will report its first quarter 2024 financial results on Thursday, May 9, 2024. Amylyx' senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the...

at 09:05
The Little Potato Company Ltd., (The Little Potato Company) North America's leader in little potatoes, celebrated the grand opening of its innovative, sustainable potato packaging facility in Nisku today. This momentous occasion signifies not only...



News published on and distributed by: